US Broker Ratings

ExxonMobil Holdings Corporation (XOM): Investor Outlook with a Steady Dividend Yield and Growth Potential

ExxonMobil Holdings Corporation (NYSE: XOM) continues to capture the attention of investors as it maintains its formidable presence in the energy sector. With a market capitalization..

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: A 30.84% Potential Upside Amidst Biotech Innovation

Rigel Pharmaceuticals, Inc. (RIGL) stands out in the biotechnology sector with a promising lineup of therapies aimed at treating hematologic disorders and cancers. Headquartered in South..

Evolent Health, Inc. (EVH) Stock Analysis: A Compelling 57.53% Upside Potential in the Healthcare Sector

Evolent Health, Inc. (NYSE: EVH), a pivotal player in the healthcare sector, is gaining attention from investors due to its significant upside potential. With the current..

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: A 79% Potential Upside with Strong Buy Ratings

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a prominent player in the biotechnology sector, is capturing investor attention with its substantial growth potential and a robust pipeline targeting..

NeoGenomics, Inc. (NEO) Stock Analysis: Growth Potential and Analyst Ratings in the Spotlight

Investors eyeing the healthcare sector might find NeoGenomics, Inc. (NASDAQ: NEO) an intriguing option. As a prominent player in the diagnostics and research industry, NeoGenomics operates..

Innoviva, Inc. (INVA) Stock Analysis: Unpacking a Potential 64.86% Upside for Investors

Innoviva, Inc. (NASDAQ: INVA), a dynamic player in the healthcare sector, particularly within the biotechnology industry, presents intriguing prospects for individual investors. With a market capitalization..

Opko Health, Inc. (OPK) Stock Analysis: Navigating a Potential 168% Upside in the Healthcare Sector

Investors with an eye on the healthcare sector may find Opko Health, Inc. (NASDAQ: OPK) an intriguing prospect, given its significant potential upside of 168.40% as..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Uncovering an 18% Growth Potential in Non-Opioid Pain Management

Pacira BioSciences, Inc. (NASDAQ: PCRX) stands at the forefront of the healthcare sector, particularly within the niche market of non-opioid pain management. With a market capitalization..

Harrow, Inc. (HROW) Stock Analysis: Eyeing a Potential 105% Upside in the Healthcare Sector

Harrow, Inc. (HROW) is making waves in the healthcare sector, specifically within the niche market of ophthalmic pharmaceuticals. With a market capitalization of $1.18 billion, this..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Exploring a 29.93% Potential Upside

Healthcare Services Group, Inc. (NASDAQ: HCSG) is making waves in the healthcare sector, attracting attention from investors with a promising potential upside of 29.93%. Headquartered in..

Janux Therapeutics, Inc. (JANX) Stock Analysis: Unpacking the 118% Potential Upside

Investors are increasingly turning their attention to Janux Therapeutics, Inc. (NASDAQ: JANX) as it emerges as a compelling player in the biotechnology sector. With its innovative..

Wave Life Sciences, Inc. (WVE): Investor Outlook on the 404.89% Potential Upside

Wave Life Sciences, Inc. (NASDAQ: WVE) presents a riveting opportunity for investors looking for high-risk, high-reward plays in the biotechnology sector. Specializing in the development of..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring a 73.87% Potential Upside

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a key player in the medical devices sector, is capturing investor attention with its promising potential upside of 73.87%. Specializing..

BioLife Solutions (BLFS) Stock Analysis: Navigating a 21.5% Revenue Growth in the Healthcare Sector

BioLife Solutions, Inc. (NASDAQ: BLFS), a key player in the healthcare sector, has garnered attention with its robust 21.5% revenue growth. Specializing in bioproduction products and..

Evotec SE (EVO) Stock Report: Exploring a Potential 164.96% Upside

Evotec SE (EVO) presents a unique investment opportunity in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Headquartered in Hamburg, Germany, Evotec..

Vera Therapeutics, Inc. (VERA) Stock Analysis: Unveiling a 138% Potential Upside in the Biotech Sector

Vera Therapeutics, Inc. (NASDAQ: VERA), a clinical-stage biotechnology company, is making waves in the healthcare sector with a focus on developing transformative treatments for immunological diseases...

Establishment Labs Holdings Inc (ESTA) Stock Analysis: 56.79% Potential Upside Beckons Investors

Establishment Labs Holdings Inc (NASDAQ: ESTA), a key player in the healthcare sector specializing in medical devices, is capturing investor attention with a potential upside of..

Biohaven Ltd. (BHVN) Stock Analysis: Unpacking the 60% Upside Potential Amidst Biotech Innovations

Biohaven Ltd. (BHVN), an emerging contender in the biotechnology sector, is capturing investor attention with its robust pipeline of innovative treatments and a compelling potential upside..

Dyne Therapeutics, Inc. (DYN) Investor Outlook: A High-Stakes Bet with 127.66% Potential Upside

For investors with an appetite for high-risk, high-reward opportunities, Dyne Therapeutics, Inc. (NASDAQ: DYN) presents a compelling case. Specializing in the biotechnology sector, this Waltham, Massachusetts-based..

Novavax, Inc. (NVAX) Stock Analysis: Navigating the Biotech Volatility with a 29.65% Upside Potential

For investors looking to delve into the dynamic world of biotechnology, Novavax, Inc. (NASDAQ: NVAX) presents an intriguing possibility. As a key player in the healthcare..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds